Pharmaceuticals, Biotechnology and Life Sciences
Phase 2 data reported at 2021 AD/PD Conference showed gamma frequency neuromodulation was safe and well tolerated
Over the 6-month period, patients in the treatment group exhibited a significant 84% slowing of functional decline in ADCS-ADL scores …
– Marketing Application in Canada (New Drug Submission) Planned for First Half of 2021
– Amylyx Also Plans to Pursue Early Access Options in Canada
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on de…
– Marketing Application in Canada (New Drug Submission) Planned for First Half of 2021
– Amylyx Also Plans to Pursue Early Access Options in Canada
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on de…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company is schedul…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company is schedul…
DUBLIN–(BUSINESS WIRE)–The “Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021” report has been added to ResearchAndMarkets.com’s offering.
The Global Clinical Stage Partnering Terms and Agreements in Pharma and Bi…
DUBLIN–(BUSINESS WIRE)–The “Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021” report has been added to ResearchAndMarkets.com’s offering.
The Global Clinical Stage Partnering Terms and Agreements in Pharma and Bi…
DUBLIN–(BUSINESS WIRE)–The “Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021” report has been added to ResearchAndMarkets.com’s offering.
The Global Clinical Stage Partnering Terms and Agreements in Pharma and Bi…
Moderna ranked number 1 overall; also ranked number 1 in the biotechnology category
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it …
Moderna ranked number 1 overall; also ranked number 1 in the biotechnology category
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it …